Funny that you think there will be an approval but that when that happens BPs will stay away. Do you think BP investors will stay away when they realize their company products are second rate at that point? Do you think they will ignore the advances made with manufacturing by NWBO or that Linda won’t point this out to them and others or that checkpoint inhibitors in generic form will be coming on line in less than 3 years? In order for your scenario to play out the investors in big pharma must remain ignorant including the institutional support they have. Do you not think that the link between the 7 market makers accused of fraud and their big pharma investments won’t become an issue once made more public with an approval? When NWBO receives the approval that you said you expect who will be viewed as the one with greatest upside potential, NWBO or the big pharmas? There are many questions that seem to have fairly obvious answers that your negative assumptions ignore. Ignorance is bliss until it’s not. Best wishes.
Market Data 
Markets 
AI
